You’ve got questions, we’ve got answers
What do HIV-1 and AIDS stand for?
HIV stands for human immunodeficiency virus-1. AIDS stands for Acquired Immune Deficiency Syndrome.
Why should I be concerned about HIV-1?
HIV-1 attacks the body’s immune system and, if left untreated over time, can cause AIDS (Acquired Immune Deficiency Syndrome).
What is DELSTRIGO?
DELSTRIGO (pronounced “del-STREE-go”) is a complete, one-pill prescription HIV-1 medicine used to treat human immunodeficiency virus-1 (HIV-1) infection in adults who have not received HIV-1 medicines in the past, or to replace their current HIV-1 medicines for people whose health care provider determines that they meet certain requirements. HIV-1 is the virus that causes AIDS.
What’s the most important information to know?
DELSTRIGO can cause serious side effects, including worsening of hepatitis B virus (HBV). If you have both HIV-1 and HBV and stop taking DELSTRIGO, your HBV may suddenly get worse. Do not stop taking DELSTRIGO without first talking to your health care provider, as they will need to monitor your health. Your health care provider should test you for HBV infection before you start treatment with DELSTRIGO.
What are the most common side effects?
In a study, the most common side effects were: dizziness 7%, nausea 5%, and abnormal dreams 5%.
DELSTRIGO may also cause serious side effects, including:
- New or worse kidney problems, including kidney failure. Your health care provider should do blood and urine (pee) tests to check your kidneys before you start and during treatment. They may tell you to stop taking DELSTRIGO if you develop new or worsening kidney problems.
- Bone problems, such as bone pain and softening or thinning (which may lead to fractures) in some people who take DELSTRIGO. Your health care provider may need to do tests to check your bones.
Tell your health care provider if you have any of the following symptoms during treatment with DELSTRIGO:
- bone pain that does not go away or worsening bone pain
- pain in your arms, legs, hands, or feet
- broken (fractured) bones; or muscle pain or weakness
These may be symptoms of a bone or kidney problem.
Changes in your immune system (Immune Reconstitution Syndrome) when you start taking HIV-1 medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. Tell your health care provider right away if you start having any new symptoms after starting your HIV-1 medicine.
These are not all the possible side effects of DELSTRIGO.
Call your health care provider for medical advice about side effects. You may report side effects to the Food and Drug Administration (FDA) at 1-800-FDA-1088.
How do I know if I should take DELSTRIGO?
Your health care provider will decide if DELSTRIGO is right for you. But until they decide, it’s important to know that you should not take DELSTRIGO if you take any of these medicines:
- St. John’s wort
Ask your health care provider or pharmacist if you are not sure if your medicine is one that is listed above. If you have taken any of the medicines in the past 4 weeks, talk to your health care provider or pharmacist before starting DELSTRIGO.
Do not take DELSTRIGO if you have ever had an allergic reaction to lamivudine.
Can I take DELSTRIGO if I’m pregnant or breastfeeding?
It is not known if DELSTRIGO can harm your unborn baby. Do not breastfeed if you take DELSTRIGO. Women with HIV-1 should not breastfeed because their babies could be infected with HIV-1 through their breast milk.
How do I take DELSTRIGO?
Take DELSTRIGO every day, exactly as your health care provider tells you to take it.
DELSTRIGO is one pill that’s usually taken by itself (without other HIV-1 medicines) once a day, at about the same time every day, with or without food.
Is there a free trial offer for DELSTRIGO?
Yes, DELSTRIGO has a free trial offer available for eligible patients.
Is there a coupon offer for DELSTRIGO?
Yes, DELSTRIGO has a coupon offer available for eligible, privately insured patients.
When did DELSTRIGO receive FDA (Federal Drug Administration) approval?
DELSTRIGO received FDA approval on August 30, 2018.